Childhood Myopia and Ocular Development
Myopia is characterized by the inability to see distant objects. Myopia results when parallel rays are focused in front of the retina with accommodation relaxed (see Image. Myopia). The global burden of myopia is rapidly increasing. In 2010, approximately 27% of the global population, or around 1.45 billion people, were affected. By 2030, half of the world population is expected to be affected by myopia. Myopia can be broadly classified as pathologic or spontaneous-onset childhood myopia. Pathologic myopia results from a rapid increase in axial length, with a usual absolute spectacle power of greater than 6 diopters (D). Rapidly progressive myopia leads to numerous degenerative changes in the retina, choroid, and sclera and therefore is termed pathologic myopia. Conversely, school-age myopia is the most common type, has a slow course, and usually stabilizes by age 20 years. Childhood myopia has emerged as one of the most significant global public health challenges of the 21st century, with rapidly increasing prevalence across diverse geographic regions and populations. Once considered a refractive condition predominantly affecting East Asian countries, myopia is now recognized as a worldwide epidemic affecting children at progressively younger ages. Results from epidemiological projections suggested that nearly half of the global population may become myopic by 2050, with a substantial proportion developing high myopia and its associated sight-threatening complications. This increasing prevalence has transformed myopia from a simple refractive error correctable with spectacles into a lifelong ocular disorder with important structural, functional, socioeconomic, and quality-of-life implications. The growing burden of childhood myopia has stimulated extensive research into the biological mechanisms governing ocular growth, environmental determinants of refractive development, and strategies for early intervention and prevention. The process of ocular development during childhood is highly dynamic and involves coordinated growth of multiple ocular structures, including the cornea, crystalline lens, anterior chamber, vitreous cavity, choroid, sclera, and retina. At birth, the human eye is relatively hyperopic because the optical power of the refractive components exceeds the axial length of the globe. During infancy and early childhood, a tightly regulated developmental process known as emmetropization gradually aligns refractive power with axial elongation, allowing the eye to achieve near-emmetropic status. This remarkable biological phenomenon relies on complex interactions between genetic programming, retinal signaling pathways, visual feedback mechanisms, and biomechanical remodeling of ocular tissues. Disruption of these finely balanced processes may result in excessive axial elongation and the subsequent development of myopia. Recent advances in developmental ophthalmology have fundamentally altered our current understanding of the pathogenesis of myopia. Rather than being viewed solely as a refractive mismatch between ocular power and axial length, myopia is increasingly recognized as a disorder of ocular growth regulation. Results from experimental studies have demonstrated that the retina actively participates in controlling eye growth through biochemical signaling cascades that influence choroidal thickness, scleral extracellular matrix remodeling, and axial elongation. Visual stimuli received by the retina are processed through local retinal mechanisms that can modulate globe growth independently of central neural pathways. These findings have established that myopia is a biologically regulated process rather than merely a hereditary refractive condition. The prevalence of childhood myopia exhibits striking geographic variation, reflecting the interplay between genetic susceptibility and environmental influences. Urban populations consistently demonstrate higher rates of myopia compared with rural communities, which suggests that lifestyle-related factors contribute significantly to disease development. Increased educational demands, prolonged near-work activities, reduced outdoor exposure, digital device usage, and altered visual environments have all been implicated in accelerating myopic progression. Contemporary children spend substantially more time engaged in indoor academic activities than previous generations, often beginning intensive educational programs at an increasingly younger age. These societal changes have coincided with a dramatic rise in myopia prevalence, reinforcing the importance of environmental modulation in refractive development. The retina plays a central role in regulating ocular growth during childhood. Results from experimental animal models have demonstrated that retinal image quality directly influences axial elongation through local biochemical pathways. Hyperopic defocus stimulates eye growth, whereas myopic defocus inhibits elongation, supporting the concept of visually guided ocular development. Neurotransmitters such as dopamine, nitric oxide, retinoic acid, and various growth factors have been implicated in these regulatory mechanisms. Dopamine, in particular, has emerged as a critical mediator of retinal signaling and may partially explain the protective effect of outdoor exposure against myopia progression. Increased retinal dopamine release in response to bright light is believed to suppress excessive axial growth, thereby reducing the risk of myopia. The choroid has gained increasing attention as an active participant in refractive regulation rather than a passive vascular layer. Dynamic changes in choroidal thickness occur in response to visual stimuli and may represent an early biomarker of ocular growth modulation. Choroidal thickening is generally associated with slowed axial elongation, whereas thinning often precedes myopic progression. These findings suggest that the choroid functions as a rapid-response tissue capable of translating retinal signals into structural changes that influence scleral remodeling and ocular growth. Advances in optical coherence tomography have enabled detailed evaluation of choroidal architecture, facilitating a deeper understanding of its role in childhood refractive development. The sclera serves as the principal structural framework governing globe size and shape. Progressive myopia is characterized by alterations in scleral extracellular matrix composition, collagen organization, biomechanical properties, and tissue remodeling. These changes reduce scleral rigidity and permit excessive axial elongation. Results from molecular studies have identified numerous pathways involved in scleral remodeling, including matrix metalloproteinases, transforming growth factor-β signaling, inflammatory mediators, and extracellular matrix regulators. Understanding these mechanisms has become increasingly important because they offer potential therapeutic targets to control myopia progression and prevent long-term structural complications. Genetic influences contribute substantially to susceptibility for childhood myopia, although inheritance patterns are complex and multifactorial. Findings from genome-wide association studies have identified numerous loci associated with refractive error, ocular growth regulation, extracellular matrix biology, and retinal signaling pathways. However, genetic predisposition alone cannot explain the rapid increase in myopia prevalence observed over recent decades. Instead, contemporary evidence supports a gene-environment interaction model in which inherited susceptibility interacts with modern visual behaviors and environmental exposures to determine individual risk. Children who have parents with myopia exhibit a greater likelihood of developing myopia, particularly when exposed to intensive educational environments and limited outdoor activities. Please see StatPearls' companion reference, "Myopia," for further information. The consequences of childhood myopia extend far beyond refractive correction. Early-onset myopia is associated with longer axial growth and a higher risk of developing high myopia in adulthood. Excessive axial elongation predisposes individuals to potentially blinding complications, including retinal detachment, myopic maculopathy, glaucoma, choroidal neovascularization, posterior staphyloma, and cataract. Consequently, childhood myopia is increasingly viewed as a chronic progressive ocular disease requiring active management rather than simple optical correction. The recognition of these long-term risks has driven the development of evidence-based myopia control strategies to slow axial elongation during critical periods of ocular development. In recent years, remarkable advances have been made in understanding the biological basis of childhood myopia and ocular growth. Innovations in imaging technologies, molecular biology, genetics, artificial intelligence, and biometric analysis have provided unprecedented insights into the mechanisms regulating refractive development. Simultaneously, emerging therapeutic interventions such as low-dose atropine, peripheral defocus contact lenses, orthokeratology, spectacle lens designs, and lifestyle modifications have demonstrated promising efficacy in slowing the progression of myopia. These developments have transformed the field from passive refractive correction toward proactive disease prevention and growth modulation. As childhood myopia continues to increase worldwide, a comprehensive understanding of ocular development and refractive regulation remains essential for developing effective strategies to preserve visual health across the lifespan. Please see StatPearls' companion reference, "Myopia," for further information.